319 related articles for article (PubMed ID: 26505137)
1. Altered purinergic signaling in the tumor associated immunologic microenvironment in metastasized non-small-cell lung cancer.
Schmid S; Kübler M; Korcan Ayata C; Lazar Z; Haager B; Hoßfeld M; Meyer A; Cicko S; Elze M; Wiesemann S; Zissel G; Passlick B; Idzko M
Lung Cancer; 2015 Dec; 90(3):516-21. PubMed ID: 26505137
[TBL] [Abstract][Full Text] [Related]
2. NTPDase1/CD39 and aberrant purinergic signalling in the pathogenesis of COPD.
Lazar Z; Müllner N; Lucattelli M; Ayata CK; Cicko S; Yegutkin GG; De Cunto G; Müller T; Meyer A; Hossfeld M; Sorichter S; Horvath I; Virchow CJ; Robson SC; Lungarella G; Idzko M
Eur Respir J; 2016 Jan; 47(1):254-63. PubMed ID: 26541524
[TBL] [Abstract][Full Text] [Related]
3. Expression profiles of Toll-like receptors in non-small cell lung cancer and idiopathic pulmonary fibrosis.
Samara KD; Antoniou KM; Karagiannis K; Margaritopoulos G; Lasithiotaki I; Koutala E; Siafakas NM
Int J Oncol; 2012 May; 40(5):1397-404. PubMed ID: 22344343
[TBL] [Abstract][Full Text] [Related]
4. Ectonucleotidase CD73 and CD39 expression in non-small cell lung cancer relates to hypoxia and immunosuppressive pathways.
Giatromanolaki A; Kouroupi M; Pouliliou S; Mitrakas A; Hasan F; Pappa A; Koukourakis MI
Life Sci; 2020 Oct; 259():118389. PubMed ID: 32898522
[TBL] [Abstract][Full Text] [Related]
5. Chronic Obstructive Pulmonary Disease Alters Immune Cell Composition and Immune Checkpoint Inhibitor Efficacy in Non-Small Cell Lung Cancer.
Mark NM; Kargl J; Busch SE; Yang GHY; Metz HE; Zhang H; Hubbard JJ; Pipavath SNJ; Madtes DK; Houghton AM
Am J Respir Crit Care Med; 2018 Feb; 197(3):325-336. PubMed ID: 28934595
[TBL] [Abstract][Full Text] [Related]
6. Unique Immune Gene Expression Patterns in Bronchoalveolar Lavage and Tumor Adjacent Non-Neoplastic Lung Tissue in Non-Small Cell Lung Cancer.
Kuo CS; Liu CY; Pavlidis S; Lo YL; Wang YW; Chen CH; Ko HW; Chung FT; Lin TY; Wang TY; Lee KY; Guo YK; Wang TH; Yang CT
Front Immunol; 2018; 9():232. PubMed ID: 29483918
[TBL] [Abstract][Full Text] [Related]
7. Protein kinase inhibitor ceritinib blocks ectonucleotidase CD39 - a promising target for cancer immunotherapy.
Schäkel L; Mirza S; Winzer R; Lopez V; Idris R; Al-Hroub H; Pelletier J; Sévigny J; Tolosa E; Müller CE
J Immunother Cancer; 2022 Aug; 10(8):. PubMed ID: 35981785
[TBL] [Abstract][Full Text] [Related]
8. Increased proteinase inhibitor-9 (PI-9) and reduced granzyme B in lung cancer: mechanism for immune evasion?
Soriano C; Mukaro V; Hodge G; Ahern J; Holmes M; Jersmann H; Moffat D; Meredith D; Jurisevic C; Reynolds PN; Hodge S
Lung Cancer; 2012 Jul; 77(1):38-45. PubMed ID: 22387007
[TBL] [Abstract][Full Text] [Related]
9. Is the purinergic pathway involved in the pathology of COPD? Decreased lung CD39 expression at initial stages of COPD.
Aliagas E; Muñoz-Esquerre M; Cuevas E; Careta O; Huertas D; López-Sánchez M; Escobar I; Dorca J; Santos S
Respir Res; 2018 May; 19(1):103. PubMed ID: 29807526
[TBL] [Abstract][Full Text] [Related]
10. Extracellular adenosine triphosphate and chronic obstructive pulmonary disease.
Lommatzsch M; Cicko S; Müller T; Lucattelli M; Bratke K; Stoll P; Grimm M; Dürk T; Zissel G; Ferrari D; Di Virgilio F; Sorichter S; Lungarella G; Virchow JC; Idzko M
Am J Respir Crit Care Med; 2010 May; 181(9):928-34. PubMed ID: 20093639
[TBL] [Abstract][Full Text] [Related]
11. Tumor-associated macrophages provide a suitable microenvironment for non-small lung cancer invasion and progression.
Wang R; Zhang J; Chen S; Lu M; Luo X; Yao S; Liu S; Qin Y; Chen H
Lung Cancer; 2011 Nov; 74(2):188-96. PubMed ID: 21601305
[TBL] [Abstract][Full Text] [Related]
12. Lung tumors, COPD and immune response: is epigenetics the bottom line?
Balestro E; Baraldo S; Piloni D; Stella GM
Minerva Med; 2016 Dec; 107(6 Suppl 1):1-8. PubMed ID: 28009152
[TBL] [Abstract][Full Text] [Related]
13. Correlation between tumor necrosis factor-alpha and D-dimer levels in non-small cell lung cancer patients.
Guadagni F; Ferroni P; Basili S; Facciolo F; Carlini S; Crecco M; Martini F; Spila A; D'Alessandro R; Aloe S; Cerasoli V; Del Monte G; Mariotti S; Mineo TC; Roselli M
Lung Cancer; 2004 Jun; 44(3):303-10. PubMed ID: 15140543
[TBL] [Abstract][Full Text] [Related]
14. Apyrase protects against allergic airway inflammation by decreasing the chemotactic migration of dendritic cells in mice.
Li P; Cao J; Chen Y; Wang W; Yang J
Int J Mol Med; 2014 Jul; 34(1):269-75. PubMed ID: 24804736
[TBL] [Abstract][Full Text] [Related]
15. Local Concentrations of CC-Chemokine-Ligand 18 Correlate with Tumor Size in Non-small Cell Lung Cancer and Are Elevated in Lymph Node-positive Disease.
Schmid S; Le UT; Haager B; Mayer O; Dietrich I; Elze M; Kemna LJ; Zissel G; Passlick B
Anticancer Res; 2016 Sep; 36(9):4667-71. PubMed ID: 27630310
[TBL] [Abstract][Full Text] [Related]
16. Insufficient CD100 shedding contributes to suppression of CD8
Wang HM; Zhang XH; Ye LQ; Zhang K; Yang NN; Geng S; Chen J; Zhao SX; Yang KL; Fan FF
Immunology; 2020 Jun; 160(2):209-219. PubMed ID: 32149403
[TBL] [Abstract][Full Text] [Related]
17. CD39+ regulatory T cells attenuate allergic airway inflammation.
Li P; Gao Y; Cao J; Wang W; Chen Y; Zhang G; Robson SC; Wu Y; Yang J
Clin Exp Allergy; 2015 Jun; 45(6):1126-37. PubMed ID: 25728362
[TBL] [Abstract][Full Text] [Related]
18. Microenvironment-Modulated Metastatic CD133+/CXCR4+/EpCAM- Lung Cancer-Initiating Cells Sustain Tumor Dissemination and Correlate with Poor Prognosis.
Bertolini G; D'Amico L; Moro M; Landoni E; Perego P; Miceli R; Gatti L; Andriani F; Wong D; Caserini R; Tortoreto M; Milione M; Ferracini R; Mariani L; Pastorino U; Roato I; Sozzi G; Roz L
Cancer Res; 2015 Sep; 75(17):3636-49. PubMed ID: 26141860
[TBL] [Abstract][Full Text] [Related]
19. Effect of IFN-gamma stimulation on expression of intercellular adhesion molecule-1 (ICAM-1) on alveolar macrophages in patients with non-small cell lung cancer.
Dabrowska M; Grubek-Jaworska H; Hoser G; Domagała-Kulawik J; Krenke R; Chazan R
J Interferon Cytokine Res; 2006 Mar; 26(3):190-5. PubMed ID: 16542141
[TBL] [Abstract][Full Text] [Related]
20. Emerging Roles of Purinergic Signaling in Diabetes.
Fotino C; Dal Ben D; Adinolfi E
Med Chem; 2018; 14(5):428-438. PubMed ID: 29485002
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
